Breast Cancer
Filters
Tucatinib (Tukadx) 150mg — HER2-Positive Breast Cancer | GLT
Generic tucatinib (Bigbear) for HER2-positive metastatic breast cancer
Tucatinib (Tukanic) 150mg — HER2-Positive Breast Cancer | GLT
Affordable generic tucatinib (Ziska) for HER2-positive metastatic breast cancer
Tucatinib (LuciTuca) 150mg — HER2-Positive Breast Cancer | GLT
Generic tucatinib (Lucius) for HER2-positive metastatic breast cancer
Tucatinib (PHOTUCA) 50mg/150mg — HER2-Positive Breast Cancer | GLT
Generic tucatinib (Pharma No.2, Laos) for HER2-positive metastatic breast cancer
Tucatinib (Tukysa) — HER2-Positive Breast Cancer | GLT
FDA-approved HER2 tyrosine kinase inhibitor for metastatic HER2-positive breast cancer
Tucatinib (Tucaxen) 150mg — HER2-Positive Breast Cancer | GLT
Affordable generic tucatinib (Everest) for HER2-positive metastatic breast cancer
LuciEver (Everolimus) 5mg/10mg Tablets | Laos Generic mTOR Inhibitor | GLT
Lucius Laos generic everolimus for RCC, neuroendocrine tumors and TSC
Ribociclib (Kisqali) 200mg*21's/14's | Novartis Switzerland | GLT
Novartis Switzerland originator Kisqali (ribociclib) 200mg, 21-tablet and 14-tablet packs for HR+/HER2- breast cancer.
Ribociclib (LuciRibo) 200mg*21's | Lucius Laos Generic | GLT
LuciRibo — Lucius Pharmaceuticals ribociclib 200mg 21 tablets for HR+/HER2- breast cancer.
Ribociclib (HER-2N) 200mg*21's | Julphar Bangladesh Generic | GLT
HER-2N — Julphar Bangladesh ribociclib 200mg 21 tablets, DGDA-certified, for HR+/HER2- breast cancer.
Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche Switzerland Originator | GLT
Roche originator Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, HER2-targeted ADC for HER2-positive breast...
UJVIRA Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Zydus India Biosimilar | GLT
Zydus UJVIRA ado-trastuzumab emtansine (T-DM1) biosimilar 100mg & 160mg vials, world's first T-DM1 biosimilar ADC...
LuciAlpe (Alpelisib) 150mg 28 Tablets | Lucius Laos Generic | GLT
LuciAlpe by Lucius Pharmaceuticals (Lao) — Lao FDA registered (03 L 1076/24) generic alpelisib, 150mg...
Vijoice (Alpelisib) 50mg/125mg/200mg Tablets | FDA-Approved PROS Therapy | GLT
Vijoice by Novartis — the first and only FDA-approved treatment for PIK3CA-Related Overgrowth Spectrum (PROS),...
Afinitor (Everolimus) 2.5mg/5mg/10mg Tablets | mTOR Inhibitor | GLT
Novartis originator everolimus in three strengths for RCC, NET and TSC
Afinitor (Everolimus) 5mg Tablets | China-Sourced mTOR Inhibitor | GLT
China-registered Novartis everolimus 5mg for RCC and neuroendocrine tumors
Qingweishi (Everolimus) 2.5mg Tablets | First Chinese Generic | GLT
CTTQ first generic everolimus, bioequivalent to Afinitor, for RCC and NET
Ribociclib (Kisqali) 200mg*21's | Novartis Taiwan, China | GLT
Novartis originator Kisqali (ribociclib) 200mg 21 tablets for HR+/HER2- breast cancer, Taiwan-sourced.
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling